Clinical Research Networking Event: February 2022 GLSA Recap
February 16, 2022
The clinical research networking event hosted by Global Life Sciences Alliance (GLSA) and FOCM on February 16, 2022 brought together professionals across drug and medical device development for learning, discussion, and connection. Special thanks to FOCM member and super-connector Nadia Bracken for helping expand our community by sharing the event.
The evening began with informal introductions and light conversation, including discussions about winter weather conditions across attendees’ locations. This relaxed opening set the tone for open dialogue and connection.
Clinical Research Networking Event Highlights
This clinical research networking event featured a short educational presentation followed by open discussion and peer networking. The featured presentation was delivered by Kalyan Ghosh, Founder and CEO of Inference, Inc., (https://inferenceinc.com/) a GLSA client. Founded in 2017, Inference brings deep expertise in biostatistics and data-driven decision-making to clinical research. Kalyan shared insights from his more than 25 years in the industry, including leadership roles at Merck, Bristol Myers Squibb, and multiple CROs. His presentation highlighted the critical role of biostatistics and data management in drug development and how these disciplines support better trial design and outcomes.
The session concluded with discussion and networking, reinforcing the value of shared learning and collaboration within the GLSA community.
The next GLSA | FOCM networking event will take place on March 16 at 7:00 PM EST. The featured presenter will be Wessam Sonbol, CEO of Delve Health, who will discuss patient-centered hybrid and decentralized clinical trial approaches.
Attendees
(Bold indicates first-time attendees)
-
Kalyan Ghosh, Inference Inc.
-
Andy Mulchinski, Symbio
-
Justin Gundelach, Mayo Clinic
-
Pauline Luong, Creative Clinical R & D
-
Chris Bergey, NaviDx
-
Brian Langin, Matrix Medical
-
Ravipal Luthra, University of Miami College of Medicine
-
Jon Matheus, A.T. Pancrazi Real Estate Services, Inc.
-
Chris Matheus, Global Life Sciences Alliance & FOCM
-
Denise McNerney, Global Life Sciences Alliance
-
Joe Buser, Global Life Sciences Alliance
-
Zulma Varela, Global Life Sciences Alliance
-
Holly Cliffe, Global Life Sciences Alliance
-
Sally Haller, Global Life Sciences Alliance
-
Hannah Lloyd, Global Life Sciences Alliance
-
Todd Neilson, Global Life Sciences Alliance
Screenshots from the event are shared below.
About GLSA
Global Life Sciences Alliance (GLSA) connects biotechs, pharma, CROs, and clinical research sites with the right experts, advisors, and solutions to accelerate development and reduce risk. With a network of more than 200 trusted partners spanning pre-clinical and clinical research, GLSA offers flexible, cost-effective access to specialized expertise and services that support early-stage biotechs, mid-size pharma, and global pharmaceutical companies.
When you need trusted, global resources to accelerate your research, GLSA helps you scale smarter and move you forward with confidence.
To learn how GLSA can support your organization, connect with Denise McNerney or Chris Matheus for a conversation about your goals and challenges.